Technical Analysis for ARKG - ARK Genomic Revolution Multi-Sector ETF
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Historical ARKG trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.22% | |
Gapped Down | Weakness | 0.22% | |
Lower Bollinger Band Touch | Weakness | 0.22% | |
Fell Below 50 DMA | Bearish | -2.83% | |
BB Squeeze Ended | Range Expansion | -2.83% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Up 2% | about 7 hours ago | |
60 Minute Opening Range Breakout | about 7 hours ago | |
Up 1% | about 7 hours ago | |
2x Volume Pace | about 9 hours ago | |
1.5x Volume Pace | about 9 hours ago |
Get a Trading Sidekick!
ARK Genomic Revolution Multi-Sector ETF Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Classification
Keywords: Exchange Traded Fund ETF Biotechnology Stem Cells Genomics Bioinformatics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 115.13 |
52 Week Low | 24.0 |
Average Volume | 6,108,028 |
200-Day Moving Average | 71.81 |
50-Day Moving Average | 103.66 |
20-Day Moving Average | 106.57 |
10-Day Moving Average | 106.34 |
Average True Range | 4.59 |
ADX | 20.04 |
+DI | 21.29 |
-DI | 38.39 |
Chandelier Exit (Long, 3 ATRs ) | 101.36 |
Chandelier Exit (Short, 3 ATRs ) | 105.03 |
Upper Bollinger Band | 115.16 |
Lower Bollinger Band | 97.97 |
Percent B (%b) | 0.05 |
BandWidth | 16.13 |
MACD Line | -0.34 |
MACD Signal Line | 1.36 |
MACD Histogram | -1.6995 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 105.08 | ||||
Resistance 3 (R3) | 105.10 | 103.05 | 104.04 | ||
Resistance 2 (R2) | 103.05 | 101.46 | 103.04 | 103.69 | |
Resistance 1 (R1) | 100.94 | 100.48 | 102.00 | 100.92 | 103.35 |
Pivot Point | 98.89 | 98.89 | 99.41 | 98.88 | 98.89 |
Support 1 (S1) | 96.78 | 97.30 | 97.84 | 96.76 | 94.33 |
Support 2 (S2) | 94.73 | 96.32 | 94.72 | 93.99 | |
Support 3 (S3) | 92.62 | 94.73 | 93.64 | ||
Support 4 (S4) | 92.60 |